NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects Drug-Related Side Effects and Adverse Reactions ✖Remove constraint Subjects: Drug-Related Side Effects and Adverse Reactions

11. On the injurious effects of mineral poisons in the practice of medicine: comprising an epitome and commentary on the system of Luigi Cornaro for attaining old age, and on the new system of medicine of F.V. Raspail (Every man his own physician), to which the Montyon Prize of 10,000 f. was lately adjudged at Paris, embracing all the details necessary for person to give this system a trial &c. &c

Author(s):
Prater, Horatio.
Publication:
London : Sherwood and Co., 1846
Subject(s):
Drug-Related Side Effects and Adverse Reactions
Inorganic Chemicals -- adverse effects
Health Behavior
Longevity
Phytotherapy
Cornaro, Luigi, 1475-1566.
Raspail, F.-V. (François-Vincent), 1794-1878.

13. Falls rates improved in Southeastern Pennsylvania: the impact of a regional initiative to standardize falls reporting

Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2012
Subject(s):
Accidental Falls -- prevention & control
Accidental Falls -- statistics & numerical data
Documentation -- standards
Interinstitutional Relations
Mandatory Reporting
Patient safety
Regional Medical Programs -- organization & administration
Aged
Data Collection -- methods
Drug-Related Side Effects and Adverse Reactions
Health Care Surveys
Hospitals
Risk Assessment
Humans
Pennsylvania
United States

15. Postmarketing adverse event reporting for medical products and dietary supplements during a pandemic

Publication:
Silver Spring, MD : Office of Counterterrorism and Emerging Threats, May 2020
Subject(s):
Dietary Supplements -- adverse effects
Drug-Related Side Effects and Adverse Reactions
Equipment Design -- adverse effects
Equipment Safety
Product Surveillance, Postmarketing
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

18. Severely debilitating or life-threatening hematologic disorders: nonclinical development of pharmaceuticals

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, March 2019
Subject(s):
Drug Evaluation, Preclinical -- standards
Hematologic Diseases -- drug therapy
Animals
Carcinogenicity Tests
Cytotoxicity Tests, Immunologic
Drug Therapy, Combination
Drug-Related Side Effects and Adverse Reactions
Immunologic Tests
Mutagenicity Tests
Pediatrics
Pharmacokinetics
Photochemistry
Safety
Toxicity Tests
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

19. REMS: FDA's application of statutory factors in determining when a REMS is necessary

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2019
Subject(s):
Drug Evaluation -- legislation & jurisprudence
Risk Evaluation and Mitigation -- legislation & jurisprudence
Cost of Illness
Drug-Related Side Effects and Adverse Reactions
Health Services Accessibility
Prescription Drugs -- adverse effects
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.

20. Oncology pharmaceuticals: reproductive toxicity testing and labeling recommendations

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, May 2019
Subject(s):
Antineoplastic Agents -- adverse effects
Mutagenicity Tests -- standards
Neoplasms -- drug therapy
Reproduction -- drug effects
Teratogens
Toxicity Tests -- standards
Contraception
Drug-Related Side Effects and Adverse Reactions
Fertility
Geriatrics
Pediatrics
Postmenopause
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.